Search Results 901-910 of 17743 for corticosteroid

1. A Study to Investigate the Effectiveness and Safety of Pf-04965842 in Subjects Aged 12 Years and Over, With Moderate to Severe Atopic Dermatitis with the Option of Rescue Treatment in Flaring Subjects - Mayo Clinic

   ... corticosteroids, calcineurin inhibitors, tars, antibiotic creams, topical antihistamines). Note: Corticosteroid inhalers and intranasal sprays are allowed ...

2. A Study Evaluating KTE-X19 in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r ALL) (ZUMA-3) - Mayo Clinic

   Corticosteroid therapy for 7 days prior to enrollment. Presence of any indwelling line or drain (e.g., percutaneous nephrostomy tube, indwelling Foley ...

3. A Study of the Outcomes of Natalizumab plus Standard Steroid Treatment for High Risk Acute Graft-Versus-Host Disease - Mayo Clinic

   Patients given only topical corticosteroids for skin GVHD are eligible. Any donor type (e.g., related, unrelated) or stem cell source (bone marrow ...

4. Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma - Mayo Clinic

   No concomitant anti lymphoma therapy, including systemic corticosteroids for the purpose of treatment of lymphoma are allowed. Topical steroids are allowed ...

5. A Study of Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma - Mayo Clinic

   Physiologic doses of systemic corticosteroids at doses which are not to exceed 10 mg/day of prednisone, or an equivalent corticosteroid;; High dose steroid ...

6. Sustained Humoral and Cell-Mediated Immunogenicity of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease - Mayo Clinic

   Group A non-biologic group: mesalamine monotherapy or thiopurine monotherapy, or corticosteroids. Group B: Anti-TNF Therapy Group: Maintenance monotherapy ...

7. Topical Composition Therapy (2013-MCN-333) for the Treatment of Melasma - Mayo Clinic

   Topical corticosteroids; Topical bleaching products; Topical retinoids. Use of systemic preparations within 1 month of study entry, including: Systemic ...

8. A 2-Part Phase 2 Study to Evaluate the Efficacy and Safety of GS-1427 in Adult Participants With Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

   Corticosteroids. Active disease despite a history of at least an induction ... 2 failed attempts to taper corticosteroids below a dose equivalent of 10 mg daily ...

9. Safety Study of SEA-CD40 in Cancer Patients - Mayo Clinic

   ... corticosteroids, or immunosuppressive drugs). Replacement therapy (e.g., thyroxine, insulin, or physiologic corticosteroid replacement therapy for adrenal ...

10. Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Monoclonal Antibody Ch14.18 in Treating Younger Patients with Refractory or Relapsed Neuroblastoma - Mayo Clinic

    ... corticosteroids while receiving treatment on this study are ineligible ... corticosteroid) as premedication for blood product administration in order ...